Alkermes plc
ALKS
Cena:
$ 36.80
-0.15 (-0.41%)
Valuace
33
Růst
15
Zdraví
70
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| BLACKROCK INC. | 29.1 mil | 17.33% | 0.00% | 0.02% | 2013-06-30 |
| BLACKROCK, INC. | 28.3 mil | 17.19% | 0.00% | 0.02% | 2024-09-30 |
| BLACKROCK FUNDING, INC. /DE | 27.9 mil | 17.05% | 0.00% | 0.02% | 2024-09-30 |
| VANGUARD GROUP INC | 18.0 mil | 10.91% | 0.00% | 0.01% | 2011-09-30 |
| BAKER BROS. ADVISORS LP | 10.0 mil | 6.08% | 0.39% | 2.03% | 2024-06-30 |
| STATE STREET CORP | 9.5 mil | 5.75% | 0.00% | 0.01% | 2013-06-30 |
| 7.4 mil | 4.51% | 0.01% | 0.01% | 2026-03-31 | |
| RENAISSANCE TECHNOLOGIES LLC | 6.2 mil | 3.74% | 0.05% | 0.34% | 2018-03-31 |
| AMERICAN CENTURY COMPANIES INC | 6.1 mil | 3.69% | 0.03% | 0.11% | 2021-09-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.7 mil | 2.83% | -0.01% | 0.02% | 2011-09-30 |
| DIMENSIONAL FUND ADVISORS LP | 4.5 mil | 2.75% | 0.01% | 0.03% | 2013-06-30 |
| COMMODORE CAPITAL LP | 4.2 mil | 2.55% | 1.98% | 8.59% | 2024-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.2 mil | 2.54% | 0.00% | 0.01% | 2011-12-31 |
| JPMORGAN CHASE & CO | 4.1 mil | 2.49% | 0.00% | 0.01% | 2022-03-31 |
| DEEP TRACK CAPITAL, LP | 3.6 mil | 2.18% | 1.08% | 2.07% | 2025-12-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.0 mil | 1.80% | 0.00% | 0.02% | 2011-12-31 |
| FIRST TRUST ADVISORS LP | 3.0 mil | 1.80% | 0.05% | 0.08% | 2013-09-30 |
| HARDMAN JOHNSTON GLOBAL ADVISORS LLC | 2.7 mil | 1.61% | -2.38% | 2.50% | 2020-03-31 |
| PRIMECAP MANAGEMENT CO/CA/ | 2.5 mil | 1.54% | 0.02% | 0.07% | 2016-06-30 |
| UBS GROUP AG | 2.5 mil | 1.54% | 0.01% | 0.01% | 2014-12-31 |
| NUVEEN, LLC | 2.5 mil | 1.49% | 0.01% | 0.02% | 2025-03-31 |
| HOLOCENE ADVISORS, LP | 2.3 mil | 1.41% | 0.20% | 0.20% | 2024-12-31 |
| CITADEL ADVISORS LLC | 2.2 mil | 1.36% | 0.01% | 0.01% | 2018-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.2 mil | 1.36% | 0.00% | 0.01% | 2011-12-31 |
| BVF INC/IL | 2.0 mil | 1.21% | 2.25% | 2.25% | 2026-03-31 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 2.0 mil | 1.20% | 1.46% | 2.82% | 2025-12-31 |
| NORGES BANK | 1.9 mil | 1.18% | 0.01% | 0.01% | 2025-12-31 |
| GOLDMAN SACHS GROUP INC | 1.9 mil | 1.14% | 0.00% | 0.01% | 2011-12-31 |
| LOOMIS SAYLES & CO L P | 1.8 mil | 1.08% | 0.02% | 0.08% | 2023-03-31 |
| MORGAN STANLEY | 1.7 mil | 1.05% | 0.00% | 0.00% | 2013-06-30 |
| PARADIGM BIOCAPITAL ADVISORS LP | 1.7 mil | 1.04% | -0.21% | 1.47% | 2025-06-30 |
| NORTHERN TRUST CORP | 1.7 mil | 1.03% | 0.00% | 0.01% | 2013-06-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.7 mil | 1.02% | 0.01% | 0.01% | 2012-03-31 |
| RTW INVESTMENTS, LP | 1.7 mil | 1.02% | 0.12% | 0.59% | 2023-09-30 |
| CAMBER CAPITAL MANAGEMENT LP | 1.5 mil | 0.92% | 0.82% | 1.00% | 2024-09-30 |
| ARMISTICE CAPITAL, LLC | 1.4 mil | 0.89% | -0.17% | 0.65% | 2020-09-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.5 mil | 0.88% | 0.00% | 0.02% | 2025-06-30 |
| AFFINITY ASSET ADVISORS, LLC | 1.4 mil | 0.82% | 0.87% | 2.47% | 2023-09-30 |
| FMR LLC | 1.3 mil | 0.80% | 0.00% | 0.00% | 2021-12-31 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.3 mil | 0.78% | -0.03% | 0.16% | 2022-03-31 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.3 mil | 0.75% | -0.02% | 0.15% | 2017-06-30 |
| BANK OF AMERICA CORP /DE/ | 1.2 mil | 0.74% | 0.00% | 0.00% | 2013-03-31 |
| AVORO CAPITAL ADVISORS LLC | 1.2 mil | 0.73% | 0.04% | 0.42% | 2024-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 1.1 mil | 0.69% | 0.01% | 0.01% | 2026-03-31 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 1.1 mil | 0.68% | 0.01% | 0.06% | 2020-03-31 |
| SQUAREPOINT OPS LLC | 1.1 mil | 0.66% | 0.02% | 0.03% | 2017-09-30 |
| BANK OF NEW YORK MELLON CORP | 1.0 mil | 0.63% | 0.00% | 0.01% | 2011-12-31 |
| JUPITER ASSET MANAGEMENT LTD | 1.0 mil | 0.61% | -0.15% | 0.26% | 2023-09-30 |
| MARSHALL WACE, LLP | 999.32 tis | 0.61% | 0.03% | 0.04% | 2025-06-30 |
| VIRGINIA RETIREMENT SYSTEMS ET AL | 976.48 tis | 0.59% | -0.01% | 0.16% | 2025-03-31 |
| PRINCIPAL FINANCIAL GROUP INC | 958.02 tis | 0.58% | 0.00% | 0.02% | 2011-12-31 |
| PICTET ASSET MANAGEMENT HOLDING SA | 942.18 tis | 0.57% | -0.01% | 0.03% | 2023-09-30 |
| PANAGORA ASSET MANAGEMENT INC | 932.94 tis | 0.57% | 0.03% | 0.12% | 2011-09-30 |
| KRENSAVAGE ASSET MANAGEMENT, LLC | 918.04 tis | 0.55% | -0.31% | 9.04% | 2019-12-31 |
| SOFINNOVA INVESTMENTS, INC. | 894.27 tis | 0.55% | 1.87% | 1.87% | 2024-12-31 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 894.28 tis | 0.54% | 0.02% | 0.02% | 2025-12-31 |
| QUANTEDGE CAPITAL PTE LTD | 881.90 tis | 0.54% | 8.61% | 9.21% | 2024-12-31 |
| GREAT POINT PARTNERS LLC | 875.04 tis | 0.52% | -0.33% | 4.14% | 2022-06-30 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 791.96 tis | 0.48% | 0.05% | 0.21% | 2025-03-31 |
| TWO SIGMA INVESTMENTS, LP | 780.68 tis | 0.47% | -0.03% | 0.02% | 2015-12-31 |
| AMERIPRISE FINANCIAL INC | 741.14 tis | 0.45% | 0.00% | 0.01% | 2012-06-30 |
| D. E. SHAW & CO., INC. | 710.30 tis | 0.43% | 0.00% | 0.02% | 2013-03-31 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 707.20 tis | 0.43% | -0.01% | 0.10% | 2021-06-30 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 700.65 tis | 0.43% | 0.11% | 0.64% | 2024-09-30 |
| FARALLON CAPITAL MANAGEMENT LLC | 691.66 tis | 0.42% | -0.14% | 0.09% | 2025-03-31 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 677.41 tis | 0.41% | 0.01% | 0.07% | 2023-12-31 |
| SIO CAPITAL MANAGEMENT, LLC | 674.84 tis | 0.41% | 5.12% | 5.12% | 2025-09-30 |
| PACER ADVISORS, INC. | 674.87 tis | 0.41% | -0.01% | 0.05% | 2023-12-31 |
| UBS ASSET MANAGEMENT AMERICAS INC | 671.43 tis | 0.41% | 0.00% | 0.00% | 2011-09-30 |
| MILLENNIUM MANAGEMENT LLC | 640.51 tis | 0.39% | 0.00% | 0.01% | 2011-12-31 |
| MAN GROUP PLC | 625.05 tis | 0.38% | 0.03% | 0.04% | 2018-03-31 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 629.59 tis | 0.38% | 0.01% | 0.07% | 2022-06-30 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 610.00 tis | 0.37% | 1.95% | 1.95% | 2026-03-31 |
| SEGALL BRYANT & HAMILL, LLC | 606.75 tis | 0.37% | 0.04% | 0.27% | 2020-03-31 |
| BALYASNY ASSET MANAGEMENT L.P. | 586.78 tis | 0.36% | 0.00% | 0.03% | 2025-12-31 |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 568.08 tis | 0.35% | 0.00% | 0.02% | 2023-09-30 |
| ACADIAN ASSET MANAGEMENT LLC | 568.68 tis | 0.34% | -0.01% | 0.03% | 2019-06-30 |
| BARCLAYS PLC | 565.03 tis | 0.34% | 0.00% | 0.00% | 2013-06-30 |
| TWO SIGMA ADVISERS, LP | 562.59 tis | 0.34% | 0.02% | 0.03% | 2015-12-31 |
| WOODLINE PARTNERS LP | 558.57 tis | 0.34% | 0.01% | 0.07% | 2023-09-30 |
| BIOIMPACT CAPITAL LLC | 549.26 tis | 0.33% | 0.81% | 2.72% | 2025-03-31 |
| INVESCO LTD. | 538.72 tis | 0.33% | 0.00% | 0.00% | 2011-12-31 |
| AQR CAPITAL MANAGEMENT LLC | 532.27 tis | 0.33% | -0.01% | 0.02% | 2017-06-30 |
| LEGAL & GENERAL GROUP PLC | 535.34 tis | 0.32% | 0.00% | 0.00% | 2016-12-31 |
| JANE STREET GROUP, LLC | 524.69 tis | 0.32% | 0.00% | 0.00% | 2019-09-30 |
| BNP PARIBAS ARBITRAGE, SNC | 527.97 tis | 0.32% | 0.00% | 0.01% | 2014-09-30 |
| EAGLE ASSET MANAGEMENT INC | 531.75 tis | 0.32% | -0.02% | 0.07% | 2020-12-31 |
| LOGOS GLOBAL MANAGEMENT LP | 500.00 tis | 0.31% | 1.68% | 1.68% | 2024-12-31 |
| GLENMEDE TRUST CO NA | 499.02 tis | 0.31% | 0.01% | 0.09% | 2021-12-31 |
| AXA S.A. | 484.43 tis | 0.30% | 0.01% | 0.04% | 2020-06-30 |
| PALO ALTO INVESTORS LP | 495.59 tis | 0.30% | -0.13% | 1.38% | 2020-12-31 |
| VOYA INVESTMENT MANAGEMENT LLC | 477.18 tis | 0.29% | 0.00% | 0.02% | 2013-06-30 |
| FEDERATED HERMES, INC. | 490.33 tis | 0.29% | 0.00% | 0.03% | 2018-12-31 |
| RHUMBLINE ADVISERS | 464.71 tis | 0.28% | 0.00% | 0.01% | 2013-06-30 |
| ENSIGN PEAK ADVISORS, INC | 460.30 tis | 0.28% | 0.03% | 0.03% | 2021-12-31 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 451.22 tis | 0.27% | -0.01% | 0.08% | 2022-03-31 |
| RICE HALL JAMES & ASSOCIATES, LLC | 429.93 tis | 0.26% | -0.01% | 0.68% | 2023-12-31 |
| RAYMOND JAMES FINANCIAL INC | 427.42 tis | 0.26% | 0.00% | 0.00% | 2024-12-31 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 422.74 tis | 0.26% | 0.04% | 0.04% | 2023-09-30 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 429.82 tis | 0.26% | 0.07% | 0.07% | 2018-12-31 |
| PFM HEALTH SCIENCES, LP | 429.57 tis | 0.26% | 0.55% | 0.55% | 2023-06-30 |
| STEMPOINT CAPITAL LP | 416.97 tis | 0.26% | 2.58% | 2.99% | 2024-09-30 |
| TD ASSET MANAGEMENT INC | 404.23 tis | 0.25% | 0.00% | 0.01% | 2023-09-30 |
| CITIGROUP INC | 405.41 tis | 0.24% | 0.00% | 0.01% | 2013-06-30 |
| ABRDN PLC | 408.98 tis | 0.24% | 0.00% | 0.02% | 2023-12-31 |
| ALLIANCEBERNSTEIN L.P. | 391.17 tis | 0.24% | 0.00% | 0.00% | 2012-06-30 |
| MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. | 376.87 tis | 0.23% | 0.83% | 0.83% | 2024-12-31 |
| LSV ASSET MANAGEMENT | 327.70 tis | 0.20% | 0.01% | 0.02% | 2023-12-31 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 323.55 tis | 0.19% | 0.00% | 0.01% | 2013-06-30 |
| SWISS NATIONAL BANK | 316.20 tis | 0.19% | 0.00% | 0.01% | 2013-06-30 |
| PRUDENTIAL FINANCIAL INC | 307.55 tis | 0.18% | 0.00% | 0.01% | 2021-06-30 |
| MACQUARIE GROUP LTD | 300.00 tis | 0.18% | 0.00% | 0.01% | 2013-06-30 |
| RAFFERTY ASSET MANAGEMENT, LLC | 288.47 tis | 0.17% | -0.01% | 0.03% | 2019-03-31 |
| MACKENZIE FINANCIAL CORP | 261.40 tis | 0.16% | 0.00% | 0.01% | 2021-09-30 |
| CAPITAL FUND MANAGEMENT S.A. | 257.96 tis | 0.15% | 0.01% | 0.02% | 2022-03-31 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 248.39 tis | 0.15% | 0.01% | 0.01% | 2024-06-30 |
| FISHER ASSET MANAGEMENT, LLC | 242.64 tis | 0.14% | 0.00% | 0.00% | 2014-06-30 |
| CANADA PENSION PLAN INVESTMENT BOARD | 227.00 tis | 0.14% | 0.00% | 0.01% | 2022-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2034 | 33.20 | 4.5 2026 | 231558 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5000 | 19.34 | 1.5 2026 | 11356 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | S-Sale | 9000 | 33.40 | 1.5 2026 | 81389 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5000 | 19.34 | 1.5 2026 | 90389 |
| Lurker Nancy | director | M-Exempt | 3751 | 0.00 | 13.4 2026 | 3752 |
| Lurker Nancy | director | F-InKind | 901 | 33.36 | 13.4 2026 | 13555 |
| Lurker Nancy | director | M-Exempt | 3751 | 0.00 | 13.4 2026 | 14456 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2034 | 34.57 | 6.4 2026 | 233592 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5000 | 19.34 | 1.4 2026 | 16356 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | S-Sale | 9000 | 35.51 | 1.4 2026 | 85389 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5000 | 19.34 | 1.4 2026 | 94389 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | A-Award | 36364 | 0.00 | 4.3 2026 | 36364 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | A-Award | 78292 | 30.25 | 4.3 2026 | 78292 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2034 | 29.76 | 4.3 2026 | 235626 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | S-Sale | 2034 | 29.29 | 4.3 2026 | 237660 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5000 | 19.34 | 4.3 2026 | 21356 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | A-Award | 38568 | 0.00 | 4.3 2026 | 38568 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | A-Award | 83037 | 30.25 | 4.3 2026 | 83037 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | S-Sale | 9000 | 29.72 | 4.3 2026 | 89389 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 5000 | 19.34 | 4.3 2026 | 98389 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | A-Award | 44078 | 0.00 | 4.3 2026 | 44078 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | A-Award | 94900 | 30.25 | 4.3 2026 | 94900 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | A-Award | 30854 | 0.00 | 4.3 2026 | 30854 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | A-Award | 66430 | 30.25 | 4.3 2026 | 66430 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | S-Sale | 6000 | 30.00 | 4.3 2026 | 109769 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | S-Sale | 6890 | 29.29 | 4.3 2026 | 7717 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | A-Award | 14176 | 0.00 | 4.3 2026 | 14176 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | A-Award | 15033 | 30.25 | 4.3 2026 | 15033 |
| POPS RICHARD F | director, officer: Director and CEO, Alkermes plc | A-Award | 88843 | 0.00 | 4.3 2026 | 88843 |
| Reed Joshua | officer: SVP, Chief Financial Officer | A-Award | 30854 | 0.00 | 4.3 2026 | 30854 |
| Reed Joshua | officer: SVP, Chief Financial Officer | A-Award | 66430 | 30.25 | 4.3 2026 | 66430 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | M-Exempt | 6866 | 0.00 | 27.2 2026 | 13732 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | F-InKind | 3049 | 30.73 | 27.2 2026 | 239694 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | M-Exempt | 6866 | 0.00 | 27.2 2026 | 242743 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 6866 | 0.00 | 27.2 2026 | 13732 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | F-InKind | 3049 | 30.73 | 27.2 2026 | 93389 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 6866 | 0.00 | 27.2 2026 | 96438 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | M-Exempt | 8322 | 0.00 | 27.2 2026 | 16645 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | F-InKind | 3695 | 30.73 | 27.2 2026 | 241308 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | M-Exempt | 8322 | 0.00 | 27.2 2026 | 245003 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | M-Exempt | 5410 | 0.00 | 27.2 2026 | 10819 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | F-InKind | 2403 | 30.73 | 27.2 2026 | 115769 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | M-Exempt | 5410 | 0.00 | 27.2 2026 | 118172 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | M-Exempt | 2747 | 0.00 | 27.2 2026 | 5493 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | F-InKind | 808 | 30.73 | 27.2 2026 | 14607 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | M-Exempt | 2747 | 0.00 | 27.2 2026 | 15415 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | M-Exempt | 7689 | 0.00 | 25.2 2026 | 7690 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | F-InKind | 3414 | 32.19 | 25.2 2026 | 235877 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | M-Exempt | 7689 | 0.00 | 25.2 2026 | 239291 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 7689 | 0.00 | 25.2 2026 | 7690 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | F-InKind | 3414 | 32.19 | 25.2 2026 | 89572 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 7689 | 0.00 | 25.2 2026 | 92986 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | M-Exempt | 8738 | 0.00 | 25.2 2026 | 8738 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | F-InKind | 3880 | 32.19 | 25.2 2026 | 236681 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | M-Exempt | 8738 | 0.00 | 25.2 2026 | 240561 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | M-Exempt | 6407 | 0.00 | 25.2 2026 | 6408 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | F-InKind | 2845 | 32.19 | 25.2 2026 | 112762 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | M-Exempt | 6407 | 0.00 | 25.2 2026 | 115607 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | M-Exempt | 2283 | 0.00 | 25.2 2026 | 2284 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | F-InKind | 672 | 32.19 | 25.2 2026 | 12668 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | M-Exempt | 2283 | 0.00 | 25.2 2026 | 13340 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | M-Exempt | 6355 | 0.00 | 20.2 2026 | 0 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | M-Exempt | 7673 | 0.00 | 20.2 2026 | 23019 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | F-InKind | 2126 | 32.02 | 20.2 2026 | 227336 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | M-Exempt | 6355 | 0.00 | 20.2 2026 | 229462 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | F-InKind | 3407 | 32.00 | 20.2 2026 | 231602 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | M-Exempt | 7673 | 0.00 | 20.2 2026 | 235009 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 8897 | 0.00 | 20.2 2026 | 0 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 7673 | 0.00 | 20.2 2026 | 23019 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | F-InKind | 3504 | 32.02 | 20.2 2026 | 81031 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 8897 | 0.00 | 20.2 2026 | 84535 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | F-InKind | 3407 | 32.00 | 20.2 2026 | 85297 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | M-Exempt | 7673 | 0.00 | 20.2 2026 | 88704 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | M-Exempt | 8897 | 0.00 | 20.2 2026 | 0 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | M-Exempt | 9300 | 0.00 | 20.2 2026 | 27903 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | F-InKind | 3796 | 32.02 | 20.2 2026 | 226653 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | M-Exempt | 8897 | 0.00 | 20.2 2026 | 230449 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | F-InKind | 4130 | 32.00 | 20.2 2026 | 231823 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | M-Exempt | 9300 | 0.00 | 20.2 2026 | 235953 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | M-Exempt | 6355 | 0.00 | 20.2 2026 | 0 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | M-Exempt | 6045 | 0.00 | 20.2 2026 | 18137 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | F-InKind | 1869 | 32.02 | 20.2 2026 | 105432 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | M-Exempt | 6355 | 0.00 | 20.2 2026 | 107301 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | F-InKind | 2277 | 32.00 | 20.2 2026 | 109200 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | M-Exempt | 6045 | 0.00 | 20.2 2026 | 111477 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | M-Exempt | 2034 | 0.00 | 20.2 2026 | 0 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | M-Exempt | 2991 | 0.00 | 20.2 2026 | 8974 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | F-InKind | 706 | 32.02 | 20.2 2026 | 9045 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | M-Exempt | 2034 | 0.00 | 20.2 2026 | 9751 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | F-InKind | 979 | 32.00 | 20.2 2026 | 11057 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | M-Exempt | 2991 | 0.00 | 20.2 2026 | 12036 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | A-Award | 25352 | 0.00 | 6.2 2026 | 230726 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | F-InKind | 7454 | 33.55 | 6.2 2026 | 75638 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | A-Award | 25352 | 0.00 | 6.2 2026 | 83092 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | F-InKind | 8626 | 33.55 | 6.2 2026 | 221552 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | A-Award | 28810 | 0.00 | 6.2 2026 | 230178 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | F-InKind | 6389 | 33.55 | 6.2 2026 | 100946 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | A-Award | 21127 | 0.00 | 6.2 2026 | 107335 |
| POPS RICHARD F | director, officer: Director and CEO, Alkermes plc | F-InKind | 62230 | 33.55 | 6.2 2026 | 1377740 |
| POPS RICHARD F | director, officer: Director and CEO, Alkermes plc | A-Award | 149580 | 0.00 | 6.2 2026 | 1439970 |
